Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Pipeline / planning |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | — |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Awarded to (7 suppliers)
| Award status: | Active |
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux – CM/PHR/22/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
22 August 2025
Closed
Estimated Value
£176,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £176,000,000 |
| Estimated Value (inc. VAT): | £211,200,000 |
| Release Date: | 7 August 2025 |
| Application Deadline: | 22 August 2025 |
| Procurement ID (OCID): | ocds-h6vhtk-05838e |
| Notice Reference: | 046995-2025 |
All 4 notices for this procurement, oldest first.
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
View Original Notice
Access the full notice on the official portal